Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease

J. E. Kreijne*, R. L. Goetgebuer, N. S. Erler, N. K. De Boer, A. G. Siebers, G. Dijkstra, F. A. van Kemenade, F. Hoentjen, B. Oldenburg, A. E. van der Meulen, C. I. J. Ponsioen, M. J. Pierik, C. J. van der Woude, A. C. de Vries*, Dutch Initiative Crohn and Colitis

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology